4K Camera Head OLYMPUS CH-S700-08-LB
Olympus Medical Systems Corp. · Decision date Sep 10, 2026
What did the FDA decide?
Olympus Medical Systems Corp. received a substantially equivalent (SESE) determination for the 4K Camera Head OLYMPUS CH-S700-08-LB under 510(k) number K262079, with a decision date of 2026-09-10 and a receipt date of 06/22/2026. The device falls under regulation 876.1500, classified as an Endoscopic Video Imaging System/Component, Gastroenterology-Urology, with primary product code FET and subsequent product code NWB. The review panel was General & Plastic Surgery, and the submission was a Traditional 510(k) not reviewed by a third party.
SESE means FDA cleared the device as substantially equivalent to a predicate; it is not a PMA approval. The FDA letter states that a substantial equivalence determination does not mean FDA has determined the device complies with all applicable requirements, and it lists registration and listing (21 CFR Part 807) and labeling (21 CFR Part 800-898) among the obligations cited. The letter also references QMSR expectations for reviewing and approving design and production changes. The available excerpts do not identify the predicate device, the specific indications for use, or the technical differences from any compared device; those details would sit in the full 510(k) summary or decision documents.
The second document excerpt mentions a model OLYMPUS CH-S700-XZ-EA and a preparation date of 02-September-2026, but the excerpt is fragmentary and its relationship to the cleared CH-S700-08-LB is not established in the public information. No clinical performance data, patient-selection criteria, or post-market conditions appear in the source material, so none are characterized here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 10, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262079
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Olympus Medical Systems Corp.
- Product code
- FET
- Decision code
- SESE
- Decision date
- Sep 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Endoscopic Video Imaging System/Component, Gastroenterology-Urology.
- Applicant
- Olympus Medical Systems Corp.
- Product code
- FET
- FDA device class
- 2
FDA decision timeline
K262079 received
Application receipt date recorded by FDA.
K262079 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Olympus Medical Systems Corp.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Tokyo
Sources and methodology
- Original FDA record: K262079
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records